Scientists at the University of California, Riverside, have discovered how adult stem cells retain their regenerative power.

Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no ...

Parkinson’s is a progressive neurological condition driven by the loss of dopamine-producing neurons, which causes tremors, ...

The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...

Two studies published in Nature found stem cell-derived products can not only be safely transplanted into the brain, but also ...

It's no secret that our waistlines often expand in middle-age, but the problem isn't strictly cosmetic. Belly fat accelerates aging and slows down metabolism, increasing our risk for developing ...

Scientists have the technology to grow humans in Petri dishes, but they say there are better uses for it: to combat aging.

As with all products, the MHRA will keep its safety under close review. The Medicines and Healthcare products Regulatory ...

The new trials used stem cell therapy to replace lost dopamine-producing ... while the other study injected seven patients with donated adult stem cells in Kyoto, Japan. In the larger of the ...

The first-line treatment for Parkinson’s is levodopa ... The cells, known as human-induced pluripotent stem cells, are ...

"Moreover, the duration of follow-up is among the longest reported for a lentiviral vector-based gene therapy; 13 patients ...

This trial enrolled 37 adult patients with CD30-positive ... and six went on to receive a stem cell transplant. The AFM13-NK cell treatment was well tolerated, with no identified cases of cytokine ...